Scientists announced a breakthrough in the treatment of diabetes

A new study dedicated to the fight against type 2 diabetes was conducted by the Centenary Institute. The results opened up for scientists the possibility of a new approach to the treatment of patients whose blood sugar level is dangerously high.

In particular, it turned out that a certain enzyme in the liver is crucial for the process of glucose regulation. It is called sphingosine kinase 2 (SphK2). According to senior study author Dr. Yanfei (Jacob) Qi, director of the Lipid Cell Biology Laboratory at the Centenary Institute, a lack of this enzyme causes the accumulation of a fatty product, which in turn impairs the function of insulin in the liver.

Remember, insulin signals fat, liver and muscle cells that it is necessary to absorb glucose from the blood. A condition in which cells do not respond to insulin properly and cannot adequately reduce glucose levels is called insulin resistance. It leads to the development of type 2 diabetes.

Dr. Qi said that their “discovery” will change life for the better. Scientists intend to continue research. In them, they plan to influence SphK2 using genetics and pharmacology. If it is possible to normalize the level of the enzyme, it will, accordingly, help in the treatment of diabetes.